With the first half of earnings season behind us, RealMoney Pro contributor Chris Versace breaks down his thoughts on companies' results and his outlook on markets going forward. Versace says earnings are contracting as expected, with the likelihood that they will continue to contract into the second and possibly even the third quarter. He predicts this may mean we don't see quite as much upside in the markets. That means investors should look for companies who are benefiting from a tailwind, an industry shift or disruptive technology -- as well as companies that are growing their revenues, earnings and profits faster than their rivals. Versace reveals what types of companies he's looking at that boast those characteristics.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.